Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 101–200 of 1,000

Inositol as putative integrative treatment for PCOS
Genazzani, A. D. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.024 · Cited by 106
MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K., Mastorakos, G. P., & Kaltsas, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 112
Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome
Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 110
Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Kazemi, M., Hadi, A., Pierson, R. A., Lujan, M. E., Zello, G. A., & Chilibeck, P. D. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa092 · Cited by 116
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
Livadas, S., Anagnostis, P. G., Bosdou, J. Κ., Bantouna, D., & Paparodis, R. D. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i1.5 · Cited by 111
2023 International Evidence‐Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta‐Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome
Tay, C. T., Mousa, A., Vyas, A., Pattuwage, L., Tehrani, F. R., & Teede, H. J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033572 · Cited by 104
The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
Guo, F., Gong, Z., Fernando, T., Zhang, L., Zhu, X., & Shi, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892125 · Cited by 110
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS
Zhang, J., Fan, P., Liu, H., Bai, H., Wang, Y., & Zhang, F. (2012) · Human Reproduction · doi:10.1093/humrep/des191 · Cited by 98
Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study
Chan, J. L., Kar, S., Vanky, E., Morin-Papunen, L. C., Piltonen, T., Puurunen, J., Tapanainen, J. S., Maciel, G. A. R., Hayashida, S. A. Y., Soares, J. M., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.04.007 · Cited by 100
Self-citation
A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Javed, Z., Papageorgiou, M., Deshmukh, H., Kilpatrick, E. S., Mann, V. M., Corless, L., Abouda, G. F., Rigby, A. S., Atkin, S. L., & Sathyapalan, T. (2019) · Nutrients · doi:10.3390/nu11010188 · Cited by 100
Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
Yılmaz, B., Vellanki, P., Ata, B., & Yıldız, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.10.018 · Cited by 101
Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
Puurunen, J., Piltonen, T., Puukka, K. S., Ruokonen, A., Savolainen, M. J., Bloigu, R., Morin-Papunen, L. C., & Tapanainen, J. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2674 · Cited by 99
Polycystic ovary syndrome: Understanding the role of the brain
Moore, A. M., & Campbell, R. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.002 · Cited by 100
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk
Amato, M. C., Verghi, M., Galluzzo, A., & Giordano, C. S. D. S. (2011) · Human Reproduction · doi:10.1093/humrep/der088 · Cited by 95
Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
Meloni, A., Dessalvi, C. C., Cugusi, L., Donataccio, M. P., Deidda, M., Sciomer, S., Gallina, S., Vassalle, C., Moscucci, F., Mercuro, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021588 · Cited by 108
High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
Garelli, S., Masiero, S., Plebani, M., Chen, S., Furmaniak, J., Armanini, D., & Betterle, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.003 · Cited by 95
Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?
Popovic, M., Sartorius, G. A., & Christ‐Crain, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00737-4 · Cited by 94
Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis
Tehrani, F. R., Amiri, M., Behboudi‐Gandevani, S., Yarandi, R. B., & Carmina, E. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 97
Self-citation
Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women
Kazemi, M., Kim, J. Y., Wan, C., Xiong, J. D., Michalak, J., Xavier, I. B., Ganga, K., Tay, C. T., Grieger, J. A., Parry, S. A., et al. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac023 · Cited by 89
Pathological pulses in PCOS
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database
Messiah, S. E., Lopez‐Mitnik, G., Winegar, D. A., Sherif, B. N., Arheart, K. L., Reichard, K. W., Michalsky, M. P., Lipshultz, S. E., Miller, T. L., Livingstone, A. S., et al. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.03.007 · Cited by 86
Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity
Estrada, E., Eneli, I., Hampl, S., Mietus-Snyder, M., Mirza, N., Rhodes, E., Sweeney, B., Tinajero-Deck, L., Woolford, S. J., & Pont, S. J. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0120 · Cited by 85
Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation
Zhang, D., Zhang, L., Yue, F., Zheng, Y., & Russell, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0589 · Cited by 86
Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
Papadakis, G. E., Kandaraki, E., Tseniklidi, E., Papalou, O., & Diamanti‐Kandarakis, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00388 · Cited by 86
Self-citation
Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis
Dobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T., Barber, T. M., & Cuthbertson, D. J. (2023) · Human Reproduction · doi:10.1093/humrep/dead053 · Cited by 89
PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis
Millán-de-Meer, M., Luque-Ramírez, M., Nattero-Chávez, L., & Escobar-Morreale, H. F. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad015 · Cited by 82
Self-citation
How should postmenopausal androgen excess be evaluated?
Rothman, M. S., & Wierman, M. E. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04040.x · Cited by 81
Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
Baldani, D. P., Škrgatić, L., & Ougouag, R. (2015) · International Journal of Endocrinology · doi:10.1155/2015/786362 · Cited by 85
Prevalence of metabolic syndrome in women with polycystic ovary syndrome
Panidis, D., Μacut, D., Τζιόμαλος, Κ., Papadakis, E. P., Mikhailidis, K., Kandaraki, E., Tsourdi, E. A., Tantanasis, T., Mavromatidis, G., & Katsikis, I. (2012) · Clinical Endocrinology · doi:10.1111/cen.12008 · Cited by 79
The Severity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS
Brower, M. A., Brennan, K., Pall, M., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2815 · Cited by 79
Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS
Hillman, J., Johnson, L. N. C., Limaye, M. A., Feldman, R., Sammel, M. D., & Dokras, A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.055 · Cited by 79
Self-citation
Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes
Graff, S. K., Mário, F. M., Alves, B. C., & Spritzer, P. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.005 · Cited by 79
Abnormally activated one-carbon metabolic pathway is associated with mtDNA hypermethylation and mitochondrial malfunction in the oocytes of polycystic gilt ovaries
Jia, L., Li, J., He, B., Jia, Y., Niu, Y., Wang, C., & Zhao, R. (2016) · Scientific Reports · doi:10.1038/srep19436 · Cited by 82
Ovarian Hypertension: Polycystic Ovary Syndrome
Bentley–Lewis, R., Seely, E. W., & Dunaif, A. E. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.009 · Cited by 83
Developmental Origin of Reproductive and Metabolic Dysfunctions: Androgenic Versus Estrogenic Reprogramming
Padmanabhan, V., & Veiga‐Lopez, A. (2011) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1275519 · Cited by 75
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark
Glintborg, D., Mumm, H., HOUGAARD, D. M., Ravn, P., & Andersen, M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03873.x · Cited by 75
Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D
Ngo, D. T. M., Chan, W. P. A., Rajendran, S., Heresztyn, T., Amarasekera, A. T., Sverdlov, A. L., O’Loughlin, P. D., Morris, H. A., Chirkov, Y. Y., Norman, R. J., et al. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.06.005 · Cited by 73
Self-citation
Hypomethylation of the LH/Choriogonadotropin Receptor Promoter Region Is a Potential Mechanism Underlying Susceptibility to Polycystic Ovary Syndrome
Wang, P., Zhao, H., Li, T., Zhang, W., Wu, K., Li, M., Bian, Y., Liu, H., Ning, Y., Li, G., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1764 · Cited by 75
Current aspects of polycystic ovary syndrome: A literature review
ANDRADE, V. H. L. D., da Mata, A. M. O. F., Borges, R. S., Costa-Silva, D. R., Martins, L. M., Ferreira, P. M. P., Nunes, L. C. C., & da Silva, B. B. (2016) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.62.09.867 · Cited by 74
Heat therapy reduces sympathetic activity and improves cardiovascular risk profile in women who are obese with polycystic ovary syndrome
Ely, B. R., Francisco, M. A., Halliwill, J. R., Bryan, S. D., Comrada, L. N., Larson, E. A., Brunt, V. E., & Minson, C. T. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00078.2019 · Cited by 74
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study
Celik, C., Taşdemir, N., Abalı, R., Baştu, E., & Yılmaz, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.050 · Cited by 74
Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method
Lerchbaum, E., Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. (2013) · Human Reproduction · doi:10.1093/humrep/det255 · Cited by 73
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 78
Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
Corrie, L., Awasthi, A., Kaur, J., Vishwas, S., Gulati, M., Kaur, I. P., Gupta, G., Kommineni, N., Dua, K., & Singh, S. K. (2023) · Pharmaceuticals · doi:10.3390/ph16020197 · Cited by 76
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)
Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?
Gunning, M. N., & Fauser, B. C. J. M. (2017) · Climacteric · doi:10.1080/13697137.2017.1316256 · Cited by 72
Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome
Caanen, M. R., Kuijper, E. A. M., Hompes, P. G. A., Kushnir, M. M., Rockwood, A. L., Meikle, W. A., Homburg, R., & Lambalk, C. B. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0699 · Cited by 70
Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins
Amiri, M., Tehrani, F. R., Nahidi, F., Kabir, A., Azizi, F., & Carmina, E. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.001 · Cited by 70
Self-citation
Inositol and human reproduction. From cellular metabolism to clinical use
Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1188282 · Cited by 69
Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
Garg, D., & Merhi, Z. O. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0205-6 · Cited by 73
What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review
Madueke-Laveaux, O. S., Elsharoud, A., & Al-Hendy, A. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225335 · Cited by 69
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 98
Decreased Cholesterol Efflux Capacity and Atherogenic Lipid Profile in Young Women With PCOS
Roe, A. H., Hillman, J., Butts, S. F., Smith, M. P., Rader, D. J., Playford, M. P., Mehta, N. N., & Dokras, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3918 · Cited by 71
Self-citation
Women-specific predictors of cardiovascular disease risk - new paradigms
Maffei, S., Guiducci, L., Cugusi, L., Dessalvi, C. C., Deidda, M., Gallina, S., Sciomer, S., Gastaldelli, A., & Kaski, J. C. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.005 · Cited by 69
“I felt like she didn’t take me seriously”: a multi-methods study examining patient satisfaction and experiences with polycystic ovary syndrome (PCOS) in Canada
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01630-3 · Cited by 68
MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndrome
Sathyapalan, T., & Atkin, S. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0755 · Cited by 69
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis
Zheng, S., Du, D., & Li, X. (2016) · Reproductive Sciences · doi:10.1177/1933719116670265 · Cited by 66
Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys
Abbott, D. H., Rayome, B. H., Dumesic, D. A., Lewis, K. C., Edwards, A. K., Wallen, K., Wilson, M. E., Appt, S. E., & Levine, J. E. (2017) · Human Reproduction · doi:10.1093/humrep/dex036 · Cited by 66
Self-citation
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia
Torky, A., Sinaii, N., Jha, S., Desai, J., El‐Maouche, D., Mallappa, A., & Merke, D. P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab133 · Cited by 70
Dispositional resilience as a moderator of the relationship between chronic stress and irregular menstrual cycle
Palm-Fischbacher, S., & Ehlert, U. (2014) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2014.912209 · Cited by 68
Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome
Whigham, L. D., Bütz, D. E., Dashti, H., Tonelli, M., Johnson, L. K., Cook, M. E., Porter, W. P., Eghbalnia, H. R., Markley, J. L., Lindheim, S. R., et al. (2014) · Current Metabolomics · doi:10.2174/2213235x01666131203230512 · Cited by 65
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome
Glintborg, D., Altinok, M., Mumm, H., Buch, K., Ravn, P., & Andersen, M. (2014) · Human Reproduction · doi:10.1093/humrep/deu133 · Cited by 65
Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review
Conte, F., Banting, L., Teede, H. J., & Stepto, N. K. (2014) · Sports Medicine · doi:10.1007/s40279-014-0291-6 · Cited by 66
Exercise and Polycystic Ovary Syndrome
Woodward, A., Klonizakis, M., & Broom, D. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_8 · Cited by 68
Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
Sangaraju, S. L., Yepez, D., Grandes, X. A., Manjunatha, R. T., & Habib, S. (2022) · Cureus · doi:10.7759/cureus.25076 · Cited by 77
Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study
Chang, A. Y., Ayers, C. R., Minhajuddin, A., Jain, T., Nurenberg, P., de Lemos, J. A., Wild, R. A., & Auchus, R. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03907.x · Cited by 64
Self-citation
Cardiometabolic risk in polycystic ovary syndrome
Studen, K. B., & Pfeifer, M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0129 · Cited by 66
Cardiometabolic risks in PCOS: a review of the current state of knowledge
Kakoly, N. S., Moran, L., Teede, H. J., & Joham, A. E. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1556094 · Cited by 71
Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review
Allen, L. A., Shrikrishnapalasuriyar, N., & Rees, A. (2021) · Clinical Endocrinology · doi:10.1111/cen.14609 · Cited by 75
Developmental Programming: Impact of Prenatal Testosterone Excess on Insulin Sensitivity, Adiposity, and Free Fatty Acid Profile in Postpubertal Female Sheep
Veiga‐Lopez, A., Moeller, J., Patel, D., Ye, W., Pease, A. P., Kinns, J., & Padmanabhan, V. (2013) · Endocrinology · doi:10.1210/en.2012-2145 · Cited by 64
Glucose intolerance states in women with the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346757 · Cited by 63
Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis
Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63
MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome
Glintborg, D., & Andersen, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0373 · Cited by 66
Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS)
Scaruffi, E., Franzoi, I. G., Civilotti, C., Guglielmucci, F., La Marca, L., Tomelini, M., Veglia, F., & Granieri, A. (2019) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2018.1530210 · Cited by 62
Pregnancy complications in polycystic ovary syndrome patients
Katulski, K., Czyzyk, A., Podfigurna-Stopa, A., Genazzani, A. R., & Męczekalski, B. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.974535 · Cited by 65
The role of vitamin D in polycystic ovary syndrome
Wu, M., & Lin, M. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.166527 · Cited by 59
Coronary artery disease risk in young women with polycystic ovary syndrome
Ding, D., Tsai, I., Wang, J., Lin, S., & Sung, F. (2018) · Oncotarget · doi:10.18632/oncotarget.23985 · Cited by 61
Testosterone a key factor in gender related metabolic syndrome
Bianchi, V. E., & Locatelli, V. (2018) · Obesity Reviews · doi:10.1111/obr.12633 · Cited by 65
Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice
Torres, P. J., Skarra, D. V., Ho, B., Sau, L., Anvar, A. R., Kelley, S. T., & Thackray, V. G. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1425-7 · Cited by 65
Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2016) · BMC Women's Health · doi:10.1186/s12905-016-0292-8 · Cited by 60
Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome—risks versus benefits
Dokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.027 · Cited by 60
Self-citation
Medical management of metabolic dysfunction in PCOS
Dulęba, A. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.11.014 · Cited by 60
Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?
Domenico, K. D., Wiltgen, D., Nickel, F. J., Magalhães, J. A. D. A., Moraes, R. S., & Spritzer, P. M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.049 · Cited by 61
Metabolic syndrome, diet and exercise
Sousa, S. M. C. D., & Norman, R. J. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.01.006 · Cited by 60
Self-citation
The Diagnostic Experiences of Women With Polycystic Ovary Syndrome (PCOS) in Ontario, Canada
Soucie, K., Samardzic, T., Schramer, K., Ly, C., & Katzman, R. (2021) · Qualitative Health Research · doi:10.1177/1049732320971235 · Cited by 56
Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
Raja-Khan, N. T., Kunselman, A. R., Hogeman, C. S., Stetter, C., Demers, L. M., & Legro, R. S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.040 · Cited by 59
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study
Pinola, P., Lashen, H., Bloigu, A. H., Puukka, K. S., Ulmanen, M., Ruokonen, A., Martikainen, H. K., Pouta, A. M., Franks, S., Hartikainen, A., et al. (2012) · Human Reproduction · doi:10.1093/humrep/des309 · Cited by 59
Advanced glycation end products: A link between metabolic and endothelial dysfunction in polycystic ovary syndrome?
Pertyńska−Marczewska, M., Diamanti‐Kandarakis, E., Zhang, J., & Merhi, Z. O. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.010 · Cited by 59
Self-citation
Weight management interventions in women with and without PCOS: a systematic review
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L. (2017) · Nutrients · doi:10.3390/nu9090996 · Cited by 58
Prevalence of Psychiatric Disorders in Patients with a Diagnosis of Polycystic Ovary Syndrome in Kashmir
Hussain, A., Chandel, R. K., Ganie, M. A., Dar, M. A., Rather, Y. H., Wani, Z. A., Shiekh, J. A., & Shah, M. S. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.150822 · Cited by 58
Síndrome de ovario poliquístico en la mujer adulta
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2018.11.019 · Cited by 66
Self-citation
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome
Thomson, R. L., Brinkworth, G. D., Noakes, M., Clifton, P. M., Norman, R. J., & Buckley, J. D. (2012) · Human Reproduction · doi:10.1093/humrep/des138 · Cited by 55
Self-citation
The androgen receptor confers protection against diet‐induced atherosclerosis, obesity, and dyslipidemia in female mice
Fagman, J. B., Wilhelmson, A. S., Motta, B. M., Pirazzi, C., Alexanderson, C., Gendt, K. D., Verhoeven, G., Holmäng, A. B., Anesten, F., Jansson, J., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-259234 · Cited by 55
Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital
Enechukwu, C. I., Onuegbu, A. J., Olisekodiaka, J. M., Eleje, G. U., Ikechebelu, J. I., Ugboaja, J., Amah, U. K., Okwara, J. E., & Igwegbe, A. O. (2019) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2019.62.5.335 · Cited by 55
Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome
Chen, P., Jia, R., Liu, Y., Cao, M., Zhou, L., & Zhao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.881684 · Cited by 56
Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals
Caanen, M. R., Schouten, N. E., Kuijper, E. A. M., van Rijswijk, J., van den Berg, M. H., Broeder, E. V. D., Overbeek, A., van Leeuwen, F. E., van Trotsenburg, M., & Lambalk, C. B. (2017) · Human Reproduction · doi:10.1093/humrep/dex098 · Cited by 54
Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study
Ollila, M., Kaikkonen, K., Järvelin, M., Huikuri, H. V., Tapanainen, J. S., Franks, S., Piltonen, T., & Morin-Papunen, L. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00570 · Cited by 53
A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome
Du, Q., Wang, Y.-J., Yang, S., Wu, B., Han, P., & Zhao, Y.-Y. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.681636 · Cited by 53

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks